China blood plasma products market is steadily growing from 2012 to more than double in 2017. It is anticipated that blood plasma products market in China will grow at a CAGR of 12.45 percent during the forecasting period and likely to reach to US$ 11,773 Million in 2025 due to combined efforts of physician education and product promotion. China is the country where over 1.3 Billion people live where prevalence of trauma, liver and hemophilia cases are steadily rising. As a result, demand of blood plasma products is high but due to lack of sufficient resources, there is huge gap between the demand and supply. Import ban on plasma product is also playing the significant role for this gap. In the china blood products market, albumin is the leading segment market which holds more than half of the total market share alone. Albumin is prescribed in China for kidney diseases, cirrhosis, cancer, and others. Chinese government has allowed only for albumin import in China.
China blood plasma product collection volume is expected to reach to 15,803 Tons in 2025 due to steadily increasing plasma protein collection center, significant growth in registered donors. China blood plasma products faces several challenges such as high entry barriers for new players, stringent regulation etc. CSL, Shire (Baxalta), Grifols, Octapharma, Hualan, RAAS, CBPO are major players in this market place.
MNG Tracker report titles “China Blood Plasma Products Market & Supply Volume by Segment (Albumin, IVIG, Factor VIII), By Albumin Market & Supply Volume (Imported, Domestic), by key Players - Albumin, IVIG (CSL, Shire (Baxalta), Grifols, Octapharma, Hualan, RAAS, CBPO)” provides in depth analysis of blood plasma products in China. This report also covers rule and regulation, growth drivers, challenges for the industry.
By Segment – Market & Forecast (2012 – 2025)
• Albumin
• IVIG
• Factor VIII
By Segment – Supply Volume & Forecast (2012 – 2025)
• Albumin
• IVIG
• Factor VIII
By Albumin – Market & Forecast (2012 – 2025)
• Total
• Imported
• Domestic
By Albumin – Supply Volume & Forecast (2012 – 2025)
• Total
• Imported
• Domestic
By Albumin – Key Players Sales & Forecast (2012 – 2025)
• CSL
• Shire (Baxalta)
• Grifols
• Octapharma
• Hualan
• RAAS
• CBPO
• Others
By IVIG – Key Players Sales & Forecast (2012 – 2025)
• Hualan
• RAAS
• CBPO
• Others
1. Executive Summary
2. China Blood Plasma Products Market Trends
2.1 Blood Plasma Products Market
2.2 Blood Plasma Protein Collection Volume
3. China Blood Plasma Products Market Share & Forecast
3.1 China Blood Plasma Products Segment Market Share
3.2 China Albumin Company Market Share
3.3 China IVIG Company Share
4. China Albumin Market Trends
4.1 Albumin Market & Forecast
4.2 Imported Albumin Market
4.3 Domestic Albumin Market
5. China Albumin Volume Trends
5.1 Total Albumin Supply Volume & Forecast
5.2 Imported Albumin Supply Volume
5.3 Domestic Albumin Supply Volume
6. Company Albumin Sales & Forecast
6.1 CSL Limited
6.2 Shire (Baxalta)
6.3 Grifols 30
6.4 Octapharma
6.5 Hualan Bio
6.6 Shanghai RAAS
6.7 China Biologic Products Holdings, Inc (CBPO)
6.8 Others
7. China IVIG Market Trends
7.1 IVIG Market & Forecast
7.2 IVIG Supply Volume & Forecast
8. Company IVIG Sales & Forecast
8.1 China Biologic Products Holdings Inc. (CBPO)
8.2 Hualan Bio
8.3 Shanghai RAAS
8.4 Others
9. China Factor VIII Market Trends
9.1 Factor VIII Market & Forecast
9.2 Factor VIII Supply Volume & Forecast
10. China Blood Plasma Products Market - Rules & Regulation
11. China Blood Plasma Products Market – Growth Drivers
11.1 Point A
11.2 Point B
12. China Blood Plasma Products Market – Challenges
12.1 Point A
12.2 Point B
12.3 Point C
Figure 2 1: China – Blood Plasma Products Market (Million US$), 2012 – 2017
Figure 2 2: China – Forecast for Blood Plasma Products Market (Million US$), 2018 – 2025
Figure 2 3: China – Plasma Protein Collection Volume (Tons), 2012 – 2017
Figure 2 4: China – Forecast for Plasma Protein Collection Volume (Tons), 2018 – 2025
Figure 3 1: China – Blood Plasma Products Segment Market Share (Percent), 2012 – 2017
Figure 3 2: China – Forecast for Blood Plasma Products Segment Market Share (Percent), 2018 – 2025
Figure 3 3: China – Albumin Company Share (Percent), 2012 - 2017
Figure 3 4: China – Forecast for Albumin Company Share (Percent), 2018 - 2025
Figure 3 5: China – IVIG Company Share (Percent), 2012 - 2017
Figure 3 6: China – Forecast for Albumin Company Share (Percent), 2018 - 2025
Figure 4 1: China – Albumin Market (Million US$), 2012 – 2017
Figure 4 2: China – Forecast for Albumin Market (Million US$), 2018 – 2025
Figure 4 3: China – Imported Albumin Market (Million US$), 2012 – 2017
Figure 4 4: China – Forecast for Imported Albumin Market (Million US$), 2018 – 2025
Figure 4 5: China – Domestic Albumin Market (Million US$), 2012 – 2017
Figure 4 6: China – Forecast for Domestic Albumin Market (Million US$), 2018 – 2025
Figure 5 1: China – Albumin Total Supply Volume (Tons), 2012 – 2017
Figure 5 2: China – Forecast for Albumin Total Supply Volume (Tons), 2018 – 2025
Figure 5 3: China – Imported Albumin Supply Volume (Tons), 2012 – 2017
Figure 5 4: China – Forecast for Imported Albumin Supply Volume (Tons), 2018 – 2025
Figure 5 5: China – Domestic Albumin Supply Volume (Tons), 2012 – 2017
Figure 5 6: China – Forecast for Domestic Albumin Supply Volume (Tons), 2018 – 2025
Figure 6 1: CSL – China Albumin Sales (Million US$), 2012 – 2017
Figure 6 2: CSL – Forecast for China Albumin Sales (Million US$), 2018 – 2025
Figure 6 3: Shire – China Albumin Sales (Million US$), 2012 – 2017
Figure 6 4: Shire – Forecast for China Albumin Sales (Million US$), 2018 – 2025
Figure 6 5: Grifols – China Albumin Sales (Million US$), 2012 – 2017
Figure 6 6: Grifols – Forecast for China Albumin Sales (Million US$), 2018 – 2025
Figure 6 7: Octapharma – China Albumin Sales (Million US$), 2012 – 2017
Figure 6 8: Octapharma – Forecast for China Albumin Sales (Million US$), 2018 – 2025
Figure 6 9: Hualan – China Albumin Sales (Million US$), 2012 – 2017
Figure 6 10: Hualan – Forecast for China Albumin Sales (Million US$), 2018 – 2025
Figure 6 11: Shanghai RAAS – China Albumin Sales (Million US$), 2012 – 2017
Figure 6 12: Shanghai RAAS – Forecast for China Albumin Sales (Million US$), 2018 – 2025
Figure 6 13: CBPO – China Albumin Sales (Million US$), 2012 – 2017
Figure 6 14: CBPO – Forecast for China Albumin Sales (Million US$), 2018 – 2025
Figure 6 15: Others – China Albumin Sales (Million US$), 2012 – 2017
Figure 6 16: Others – Forecast for China Albumin Sales (Million US$), 2018 – 2025
Figure 7 1: China – IVIG Market (Million US$), 2012 – 2017
Figure 7 2: China – Forecast for IVIG Market (Million US$), 2018 – 2025
Figure 7 3: China – IVIG Supply Volume (Tons), 2013 – 2017
Figure 7 4: China – Forecast for IVIG Supply Volume (Tons), 2018 – 2025
Figure 8 1: CBPO – China IVIG Sales (Million US$), 2012 – 2017
Figure 8 2: CBPO – Forecast for China IVIG Sales (Million US$), 2018 – 2025
Figure 8 3: Hualan – China IVIG Sales (Million US$), 2012 – 2017
Figure 8 4: Hualan – Forecast for IVIG Albumin Sales (Million US$), 2018 – 2025
Figure 8 5: Shanghai RAAS – China IVIG Sales (Million US$), 2012 – 2017
Figure 8 6: Shanghai RAAS – Forecast for China IVIG Sales (Million US$), 2018 – 2025
Figure 8 7: Others – China IVIG Sales (Million US$), 2012 – 2017
Figure 8 8: Others – Forecast for China IVIG Sales (Million US$), 2018 – 2025
Figure 9 1: China – Factor VIII Market (Million US$), 2012 – 2017
Figure 9 2: China – Forecast for Factor VIII Market (Million US$), 2018 – 2025
Figure 9 3: China – Factor VIII Supply Volume (Million IUs), 2012 – 2017
Figure 9 4: China – Forecast for Factor VIII Supply Volume (Million IUs), 2018 – 2025
Figure 10 1: China – Plasma Protein Collection Center (Numbers), 2012 – 2017
Figure 10 2: China – Forecast for Plasma Protein Collection Center (Numbers), 2018 – 2025
China Blood Plasma Products Market & Supply Volume by Segment (Albumin, IVIG, Factor VIII), By Albumin Market & Supply Volume (Imported, Domestic), by key Players - Albumin, IVIG (CSL, Shire (Baxalta), Grifols, Octapharma, Hualan, RAAS, CBPO)
